Age: 26
Free Agency: 2024 (UFA)
Accrued Seasons: 5
- Height: 6'0"
- Weight: 233
- College: Penn State
- Entry: 2018 Draft, Round 1, #2 overall (Giants)
- 2023 Salary Cap Charge: $10,091,000 (4.41% of cap)
- 2023 Cash Payout: $10,091,000 (4.46% of spending)
- 2023 Cash to Cap Ratio: 1.00
- Contract Value: $10,091,000 ($10,091,000 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 10/160 at RB
Current Contract
(Franchise, signed 2023)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2023 | 26 | $10,091,000 | $10,091,000 | 4.4% | ||||
| Total | $10,091,000 | $10,091,000 | ||||||
Contract Notes
Saquon Barkley, the 2nd overall pick in the 2018 NFL draft, signed a four year contract with the Giants worth $31,194,750. The entire contract is fully guaranteed and Barkley received a $20.767 million signing bonus. He will earn guaranteed training camp roster bonuses from 2019 through 2021.
Cash Flows
| 2023 | |
|---|---|
| Cash Due | $10,091,000 |
| Running Cash | $10,091,000 |
Career Earnings: $38,601,750
Career APY: $7,720,350
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Giants | Drafted | Expired | 2018 | 4 | $31,194,750 | $7,798,688 | $31,194,750 | $38,601,750 | 123.7% | $7,720,350 |
| Giants | Franchise | Active | 2023 | 1 | $10,091,000 | $10,091,000 | $0 | $0 | 0.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Giants | 5 | $38,601,750 | $7,720,350 | $38,601,750 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | Giants | $480,000 | $5,191,773 | $0 | $480,000 | $5,671,773 | 3.2% | $21,247,092 | ||
| 2019 | Giants | $570,000 | $5,191,773 | $1,327,943 | $1,897,943 | $7,089,716 | 3.6% | $1,897,943 | ||
| 2020 | Giants | $750,000 | $5,191,773 | $2,655,886 | $3,315,886 | $8,597,659 | 4.4% | $3,405,886 | ||
| 2021 | Giants | $850,000 | $5,191,773 | $3,983,829 | $4,733,829 | $10,025,602 | 5.4% | $4,833,829 | ||
| 2022 | Giants | $7,217,000 | $0 | $0 | $7,217,000 | $7,217,000 | 3.5% | $7,217,000 | ||
| 2023 | Giants | $10,091,000 | $0 | $0 | $0 | $10,091,000 | 4.4% | $10,091,000 | ||
| Total | $19,958,000 | $20,767,092 | $7,967,658 | $17,644,658 | $48,692,750 | $48,692,750 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | Rushing | Receiving | Fumbles | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | Att | Yards | Avg | TD | Rec | Yards | Avg | TD | Total | Lost | ||
| 2018 | 16 | 0 | 0 | 82.7% | 0.4% | 261 | 1307 | 5.0 | 11 | 91 | 721 | 7.9 | 4 | 0 | 0 |
| 2019 | 13 | 3 | 0 | 68.2% | 0.2% | 217 | 1003 | 4.6 | 6 | 52 | 438 | 8.4 | 2 | 1 | 0 |
| 2020 | 2 | 0 | 0 | 6.6% | 0.0% | 19 | 34 | 1.8 | 0 | 6 | 60 | 10.0 | 0 | 0 | 0 |
| 2021 | 13 | 4 | 0 | 46.6% | 0.0% | 162 | 593 | 3.7 | 2 | 41 | 263 | 6.4 | 2 | 0 | 0 |
| 2022 | 16 | 0 | 1 | 75.4% | 0.4% | 295 | 1312 | 4.4 | 10 | 57 | 338 | 5.9 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $10,875,000 | $10,091,000 |
| Injury Adjusted | $10,875,000 | $10,091,000 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.